BACKGROUND: There is a growing use of procalcitonin (PCT) to facilitate the diagnosis and management of severe sepsis. We investigated the impact of one to two PCT determinations on ICU day 1 on health-care utilization and cost in a large research database.
More than $20 billion was spent on sepsis care in 2011, making it the most expensive condition managed in US hospitals. 1 Sepsis is increasingly common, and despite advances in antimicrobial and supportive therapy, it continues to be associated with a high risk for morbidity and mortality. 2 The current consensus sepsis definition has been found to be both nonspecific and nonsensitive. 3 Lack of a "gold standard" diagnostic test for sepsis has resulted in diagnostic dilemmas that may delay appropriate treatment and lead to poor outcomes. [3] [4] [5] Unnecessary antibiotic use, as a consequence of sepsis overdiagnosis, is associated with increased length of stay (LOS), drug-related toxicities, Clostridium difficile infection, antimicrobial resistance, and health-care costs. 6 Optimizing outcomes and minimizing resource utilization are contingent on timely and accurate discrimination between sepsis and mirroring conditions.
Procalcitonin (PCT), a precursor of calcitonin, has good specificity for a bacterial cause of suspected infection 7, 8 and has been investigated for the diagnosis of bacterial infection, prognosis of sepsis, and management of antibiotic therapy. [9] [10] [11] [12] [13] [14] [15] PCT guidance has been shown to reduce duration of antibiotic use in sepsis with no beneficial or detrimental impact on survival. 10 Despite the emergence of PCT evaluation as a diagnostic criterion for sepsis in the 2012 Surviving Sepsis Campaign Guidelines, PCT testing has not been uniformly adopted, in part because of cost considerations. 16 However, a Dutch study showed that PCT-based algorithms lowered hospital spending by V3503 per patient, saving the Netherlands health system an estimated V46 million annually. 9 To provide current real-world information on healthcare utilization and cost, we evaluated the impact of PCT testing performed on the first day of ICU admission in critically ill adult patients with suspected sepsis. An enhanced administrative database was used that included discharges from >550 US hospitals.
Patients and Methods
This study was a retrospective trial of patients aged $18 years admitted to an ICU with an admitting or discharge diagnosis code consistent with suspected or documented sepsis, septicemia, systemic inflammatory response syndrome, or shock (e- Table 1 ) between January 1, 2011, and May 31, 2014. Patients were grouped into those who did or did not receive 1 or 2 PCT determinations around the time of ICU admission. The initial PCT testing may occur in the ED or on the floor, but the PCT-tested patients were excluded if they received PCT determinations >2 days before or after ICU admission. The reason for PCT testing and the result were not specified in the administrative database that was used for the study. The database does not contain data to define the physician specialty who ordered the test or the patient characteristics that led to testing. The study design and methods were reviewed and approved by the Rush University Medical Center Office of Research Affairs per policy RA-IRB-118.
The data source was the Premier Healthcare Database, a large US hospital-based, service-level, all-payer administrative database. Utilization, cost, and outcome data were directly available in the database. Total antibiotic exposure was calculated as the total number of selected systemic antibiotics (e- Table 2 ) on a given day summed over the entire course of administration such that three antibiotics administered daily over 7 days would equal 21 days of exposure.
Because patients were not randomly assigned to PCT and non-PCT cohorts, differences in patient characteristics and severity may lead to bias in the estimated effect of PCT. To address this issue, 1:3 propensity score matching was implemented by using nearest neighbor matching to account for differences in the comparison groups. 17 The analysis was limited to patients with a PCT determination within 1 day of ICU admission. Despite this approach, there were some control subjects with very short ICU stays who were discharged before the time that the PCT determination was run on the matched case. These control subjects were dropped because the shorter stays could not be attributable to a "treatment effect" (relating to whether a PCT determination was or was not obtained). Propensity scores were determined by using a logistic regression with receipt of PCT testing as the dependent variable and the following covariates: patient demographic characteristics (age categories, sex, race, ethnicity, healthcare coverage type, and year of hospitalization), hospital characteristics (urbanicity, teaching status, bed size, and region), and patient's clinical characteristics (admission type, admission source, number of types of antibiotics received on the first ICU day, dialysis on or before the first ICU day, ventilator use on or before the first ICU day, use of vasopressors or inotropes on the first ICU day, previous hospitalization within 30 days, and presence of the 10 most frequent admission diagnoses). After propensity score matching, the balancing properties of the matching covariates were examined through a review of the standardized differences between the PCT group and the non-PCT group. Standardized differences <0.1 were considered negligible. 18, 19 Descriptive statistics of the outcomes were generated, and bivariate analysis was implemented on the propensity score-matched sample. The analytic and data processing plan are depicted in e- Figure 1 .
Data measured on a continuous scale were summarized by using means; 95% CIs of the mean for the outcomes are also reported. Categorical data are expressed as counts and percentage of patients within each category. Bivariate analysis was performed to compare variables between those patients receiving PCT testing and those who did not. A t test was used to evaluate continuous variables, and c 2 tests were used for categorical variables. P values <.05 were considered statistically significant.
Multivariable regression models were used to assess the association between PCT test and outcomes in the propensity score-matched sample. Control variables included the following: patient demographic characteristics (age categories, sex, race, ethnicity, health-care coverage type, and year of hospitalization), hospital characteristics (urbanicity, teaching status, bed size, and region), and patient's clinical characteristics (admission type, admission source, number of different types of antibiotics received on the first ICU day, dialysis on or before the first ICU day, ventilator use on or before the first ICU day, use of vasopressors or inotropes on the first ICU day, previous hospitalization within 30 days, and presence of the 10 most frequent discharge diagnoses such as septicemia, other lung diseases, pneumonia with organism unspecified, heart failure, acute myocardial infarction, replacement and graft complication, other surgical complications that were not elsewhere classified, other bacterial pneumonia, acute renal failure, chronic bronchitis, pneumonitis due to solids and liquids, cardiac dysrhythmias, other forms of chronic ischemic heart disease, diabetes mellitus, and complications of medical care that were not elsewhere classified). A supplemental analysis included the CareScience Mortality Risk Model score, a predictive value derived from clinical and demographic characteristics and available for those not transferred to another inpatient facility. 20 This score is calculated based on diagnosis codes and is available in the Premier Healthcare Database. Because we conducted a retrospective observational study using a hospital administrative database, the information needed to calculate The Acute Physiology and Chronic Health Evaluation Score (APACHE) or Simplified Acute Physiology Score (SAPS) (eg, vital signs, laboratory values) was not necessarily available, and these severity-of-illness scores could therefore not be determined. The missing values of the CareScience Mortality Risk Model score were due to the fact that some patients were transferred to other acute care facilities, and their mortality was not known. Because the basic assumption for imputation is that the missing values should be missing at random, the imputation may bring in bias for the group of patients transferred to another facility.
Generalized estimating equation models were used to model LOS, costs, and days of antibiotic therapy. These models with an exchangeable correlation structure generated robust variance estimates by adjusting for the within-hospital correlation. Logistic regression was used to model discharge status. The recycled prediction method 21 was used to calculate the adjusted outcome values. Recycled prediction method is a way to calculate the predicted outcomes based on regression estimates. First, all patients were assumed to receive PCT, and the adjusted outcomes were predicted based on the regression coefficients, holding all covariates at their actual values. Second, predication was made assuming all patients were in the non-PCT cohort. The mean differences in the predicted values for the two hypothetical groups (PCT and non-PCT) were examined and the 95% CIs calculated by using the bootstrapping method. All statistical analyses were performed by using SAS version 9.2 (SAS Institute, Inc).
Results
This study evaluated 15,041,827 patients in the Premier Healthcare Database universe of patients; 730,088 had a potential sepsis, systemic inflammatory response syndrome, septicemia, or shock-related diagnosis on admission or discharge and were cared for in the ICU (Fig 1) . This cohort was further stratified according to whether one or two PCT levels were obtained within the first day of ICU admission (n ¼ 34,989) vs the non-PCT-managed cohort of ICU patients (n ¼ 671,473). To reduce potential bias, a 1:3 propensity matching was performed. After matching, there were 98,543 non-PCTmanaged patients at 570 hospitals and 33,569 PCTmanaged patients at 286 hospitals. The data cleaning step to correct for the patients with extremely short stays affected 3% of control subjects. In most of these cases, the net effect was that <2% of cases had two or one rather than three matched control subjects. In 1% of case subjects, all three control subjects were affected; these cases were dropped. Even in this small number of affected patients, the numerical effect cannot be large because of the very short stays involved.
There was no difference between the groups in the percentage of admissions from rural and urban hospitals, teaching and nonteaching hospitals, and bed size of the included hospitals (e- Table 3 ). The study populations were well matched for age, sex, race, ethnicity, health-care insurance status, and admission type ( Table 1) . The admission diagnosis, when present, was also similar between the two groups. No significant differences were noted in the number of systemic antibiotics administered to patients on the first day of their ICU stay or in the use of mechanical ventilatory support on or before the first day of ICU stay. There was Propensity score-matched PCT cohort (n = 33,569) (286 hospitals) Figure 1 -Graphic illustration of the study flow from the Premier Healthcare Database universe of patients sorted according to ICU stay and selected sepsis, systemic inflammatory response syndrome, septicemia, and shock diagnoses and further sorted according to the use of PCT during the admission. Subsequent sorting used PCT testing on day 1 of ICU admission and a propensity score to match the study populations. PCT ¼ procalcitonin.
journal.publications.chestnet.org no statistically significant difference in the use of vasopressors and/or inotropic medications on the first day of ICU stay for the two groups of patients. Figure 2 displays the success of the propensity score adjustment in the matched outcomes analysis without regression adjustment. In unadjusted analysis, PCTguided care was associated with a significantly shorter hospital and ICU LOS ( Table 2) . PCT-guided care was also associated with significantly decreased total hospital, room and board, pharmacy, antibiotic, and laboratory costs. Antibiotic exposure was lower in the PCT-managed patients. More PCT-managed patients were discharged home, but inpatient mortality was slightly higher in this group. The PCT group was also less likely to be transferred to acute care, skilled nursing, intermediate care, or long-term care facilities.
Multivariable regression adjustment was performed to further address residual imbalances between patient and hospital characteristics. This analysis generally substantiated and refined the findings of the unadjusted matched analysis ( 
Discussion
PCT testing on the first day of ICU care has received US Food and Drug Administration (FDA) clearance as a tool to assist in the identification of patients with a high likelihood of sepsis. A growing number of hospitals have adopted PCT testing to aid in the diagnosis and management of patients with potential sepsis. This study evaluated the large Premier Healthcare Database, which contained data from >619 million patient encounters (inpatient and outpatient) or approximately one in every five discharges in the nation over nearly 3.5 years to assess the impact of first ICU day PCT testing on health-care utilization and cost of care in adults with potential sepsis. Although this sample was not random, preliminary comparisons between patient and hospital characteristics for the hospitals that submit data to Premier and those of the To date, there is no approved "septic test" that identifies patients with sepsis with a sufficiently high likelihood to make it clinically useful. 23 PCT has been used, predominantly in Europe, to assist in identifying patients with respiratory infections who would benefit from antibiotic treatment. 6, 8, [23] [24] [25] [26] [27] Studies have also suggested a potential benefit of using PCT testing to help with ICU prognosis and antibiotic stewardship related to decreasing antibiotic exposure. 10, [24] [25] [26] [27] [28] [29] Neither of these uses has gained FDA approval.
The present study showed that the use of PCT testing on the first day of ICU care was associated with significantly lower hospital and ICU LOS. There was also a significant difference in the total hospital, ICU, and pharmacy costs when day 1 PCT testing in the ICU was used in critically ill adult patients. The PCT-managed patients had less total antibiotic exposure but higher laboratory costs. The all-patient analysis revealed a statistically significant, but only slightly higher (0.7%), risk of mortality that was not observed in an enhanced risk-adjusted analysis that included 96% of patients. This outcome is consistent with numerous prospective studies involving thousands of patients that have found no difference in mortality or other clinical outcomes using PCT guidance. [24] [25] [26] 28, 30 The interpretation of the latter findings is not readily apparent. One would certainly expect that more rapid identification and management of patients with sepsis would have also translated into improved survival in addition to improved health-care utilization and cost of care. 16, 23, 31 Unfortunately, we cannot control for differences in severity of illness or chronic health conditions between the two cohorts, which may have affected survival. Similarly, we lacked information on subsequent use of vasopressors, ventilator support, renal replacement therapy, and other aspects of support that may influence outcome of the patient with sepsis. 16, 23, [31] [32] [33] [34] [35] Another important factor that affects overall survival is the limitation and/or withdrawal of care, which can have a significant effect on overall outcome and does not necessarily reflect the adequacy of sepsis management but rather patient/family preferences or desires regarding end-of-life care. 16 The present study is important in the validation of PCT testing's ability to favorably affect the outcome of critically ill patients when used according to the FDA-cleared guideline. The study population was large and extremely diverse. The use of PCT was evaluated over nearly a 3.5-year period and in a variety of clinical settings, including academic and nonacademic institutions. The cost savings were real and consequential, exceeding the potential increased costs of laboratory testing associated with PCT testing on ICU admission.
The mechanisms resulting in the improved health-care utilization and cost of care are not immediately evident from this administrative database. It seems likely that PCT is being used both to help rule-out and rule-in sepsis on ICU admission. The former would directly save resources, whereas the latter would translate into earlier administration of appropriate antibiotic therapy and source control (ie, key components of sepsis management). 16, 23 In addition, earlier recognition of the patient with sepsis may allow for earlier use of the appropriate resuscitation and management protocols (eg, the Surviving Sepsis Campaign Management Guideline), which have also been associated with improved outcome for patients with sepsis. 16, 23, [31] [32] [33] [34] [35] Improved management using early effective appropriate antibiotics, source control, and fluid/vasopressor administration would be expected to lead to earlier patient improvement, reduced LOS, and decreased health-care utilization and cost. 16, 31, 35 These outcomes were noted in this large patient population from a diverse group of hospitals and patient care settings.
The suspected timely and improved sepsis management in the PCT-managed patients was associated with decreased hospital, ICU, and pharmacy costs. These patients also required less antibiotic treatment as journal.publications.chestnet.org evidenced by decreased antibiotic exposure, which may have future implications on the ever-growing problem of bacterial resistance and development of multidrugresistant organisms. Because patients with PCT testing after the first day of ICU care were not included in this database, it is unlikely that PCT was used to guide early antibiotic discontinuation. The higher laboratory costs (<$100) related to the use of PCT in the management of these critically ill patients may reflect the additional cost of PCT testing.
The major limitations of the present study include the retrospective nature of the analysis and the lack of clinical and certain other data. The identification of PCT testing was based on a text string search in the hospital billing records. Because hospitals recorded the cost of laboratory tests in various ways, we might not have captured all PCT tests in the hospitals. Second, as in all retrospective observational studies, the PCT and non-PCT cohorts were not randomly assigned. Therefore, there is a potential bias due to the difference in patient severity and unmeasured confounders. Although propensity score matching and multivariable analysis were implemented to control for the patient's severity as much as possible, unobservable characteristics may still exist that were not controlled for in the analysis. The database lacked specific information as to whether there were hospital protocols governing the use of PCT in patient management or ICU admission. Similarly, there were no data regarding confirmatory culture results, the presence and site of actual infection, the adequacy of initial empiric antibiotic therapy, and/or source control measures, which may all affect outcome. 16, 23, [32] [33] [34] There were also no data on subsequent need for vasopressor/inotropic therapy, ventilator support, renal replacement therapy, or the severity of illness, comorbidities, or limitations on aggressive care between the two groups, which could have affected treatment decisions and outcomes. All of these factors may influence health-care utilization and outcomes in severe sepsis and septic shock. Not all hospitals had onsite PCT testing available, and we do not have information protocols or decision processes that determined which patients would undergo PCT testing.
Conclusions
This evaluation of adult patients from US hospitals in the Premier Healthcare Database suggests that use of PCT testing on ICU admission was associated with a significant decrease in hospital and ICU LOS, less systemic antibiotic exposure, a slight increase in laboratory costs, and decreased hospital, ICU, and pharmacy costs. The significance and mechanisms surrounding the observed clinical outcomes warrant additional evaluation.
